STOCK TITAN
  1. Home
  2. News
  3. RCM

R1 RCM Inc. - RCM STOCK NEWS

Welcome to our dedicated news page for R1 RCM (Ticker: RCM), a resource for investors and traders seeking the latest updates and insights on R1 RCM.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect R1 RCM's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of R1 RCM's position in the market.

News
R1 RCM to Acquire Acclara
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) has entered into a definitive agreement to acquire Acclara, a leading technology-driven revenue cycle management company, from Providence, and has been selected by Providence as its long-term revenue cycle management partner. The partnership lays the foundation for R1 to continue to automate revenue management and to extend its scale and diversification to build long-term value for providers, patients, and shareholders. The proposed acquisition of Acclara and 10-year Providence partnership demonstrate the strength and flexibility of the R1 business model, and R1’s ability to deploy advanced technology solutions and drive execution across revenue cycle management processes to improve customer and patient outcomes. R1 expects the transaction to provide a foundation for additional growth opportunities by expanding the end-to-end relationship with Providence and other Acclara customers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.82%
Tags
acquisition
-
News
R1 Completes Restatement of Previously Issued Financial Statements
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) has completed the restatement of its financial statements for 2022 and 2021, with no material impact on revenue or Adjusted EBITDA. The restatement had no impact on the company's cash, business operations, or 2023 outlook.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.56%
Tags
none
-
News
R1 RCM Receives Notice of Filing Delinquency from Nasdaq
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) received a letter from Nasdaq’s Listing Qualifications Department due to a delay in filing its Quarterly Report. The delay was caused by the Company's determination to restate certain previously issued financial statements. The notice requires the Company to submit a plan to regain compliance within 60 days, with a possible extension of up to 180 days. The Company intends to file the Form 10-Q as soon as possible.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
R1 RCM to Restate Certain Previously Issued Financial Statements Due to Errors in Accounting for Expenses Associated with Historical Acquisitions
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) Restates Financial Statements for 2022 and 2021, No Material Impact on 2023 Results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.49%
Tags
acquisition
-
News
R1 RCM to Present at Upcoming Investor Conferences
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) to present at 2023 Stephens Annual Investment Conference and 6th Annual Evercore ISI HealthCONx Conference, offering live webcasts and replays on r1rcm.com
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
conferences
-
News
R1 RCM expands collaboration with Microsoft to accelerate integration of Azure OpenAI Service across the R1 enterprise
Rhea-AI Summary
R1 RCM Inc. has announced an expansion of its collaboration with Microsoft to integrate generative AI into its healthcare revenue cycle management platform. The company has launched its first large language model (LLM) application that improves physician coding quality. The application uses Microsoft Azure AI services to evaluate medical records and predict physician evaluation and management codes, improving coding quality across patient charts. R1 plans to leverage LLMs on applications across the revenue cycle to achieve greater automation and improve patient satisfaction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.25%
Tags
none
News
R1 RCM Reports Third Quarter 2023 Results
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) announced its third quarter 2023 results, reporting a revenue of $572.8 million, a 15.5% increase compared to the same period last year. The company also achieved a GAAP net income of $1.3 million, compared to a net loss of $29.5 million in the same period last year. Adjusted EBITDA reached $161.5 million, a 30.2% increase compared to the same period last year. R1 expects to generate a revenue of $2,255 million to $2,275 million for 2023. The company's management team will host a conference call to discuss the financial results and business outlook.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.25%
Tags
earnings
-
News
R1 RCM to Release Third Quarter 2023 Results on November 2
Rhea-AI Summary
R1 RCM Inc. to release financial results for Q3 2023 on November 2, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.22%
Tags
earnings
-
News
James Hardie Industries Announces Global Leadership Appointment
Rhea-AI Summary
James Hardie Industries plc has announced the appointment of Rachel Wilson as Chief Financial Officer. Wilson brings over 25 years of experience in the technology, business services, and consumer products industries. She will report directly to CEO Aaron Erter. Wilson's appointment follows the departure of Jason Miele, who will remain with the company for three months as an advisor to the CEO for special projects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
none
News
R1 RCM Reports Second Quarter 2023 Results
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) announced second quarter results with revenue of $560.7 million, up 43.1% from the same period last year. The company reported a GAAP net income of $0.3 million, compared to a net loss of $20.4 million last year. Adjusted EBITDA was $142.9 million, up 63.9% from last year. The results were impacted by a $11.6 million increase in the reserve for credit losses related to a physician customer. The company expects revenue of $2,255 million to $2,275 million for 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.23%
Tags
earnings
Stock RCM logo
R1 RCM Inc.

Nasdaq:RCM

RCM Rankings

#1172 Ranked by Market Cap
#4178 Ranked by Stock Gains
N/A Ranked by Dividends

RCM Stock Data

5.25B
291.50M
1.09%
104.14%
2.85%
Health Information Services
Healthcare
Link
US
Chicago

About RCM

R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.